Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing

Authors:

Abstract
Here we introduce a mostly natural sequencing-by-synthesis (mnSBS) method for single-cell RNA sequencing (scRNA-seq), adapted to the Ultima genomics platform, and systematically benchmark it against current scRNA-seq technology. mnSBS uses mostly natural, unmodified nucleotides and only a low fraction of fluorescently labeled nucleotides, which allows for high polymerase processivity and lower costs. We demonstrate successful application in four scRNA-seq case studies of different technical and biological types, including 5′ and 3′ scRNA-seq, human peripheral blood mononuclear cells from a single individual and in multiplex, as well as Perturb-Seq. Benchmarking shows that results from mnSBS-based scRNA-seq are very similar to those using Illumina sequencing, with minor differences in results related to the position of reads relative to annotated gene boundaries, owing to single-end reads of Ultima being closer to gene ends than reads from Illumina. The method is thus compatible with state-of-the-art scRNA-seq libraries independent of the sequencing technology. We expect mnSBS to be of particular utility for cost-effective large-scale scRNA-seq projects.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5RM1HG006193-09, R44HG010558, R44HG011060)
  • U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (5F32AI138458)
  • Howard Hughes Medical Institute
  • Klarman Cell Observatory, Broad Institute of MIT and Harvard
  • Broad Institute | Stanley Center for Psychiatric Research, Broad Institute
  • Klarman Cell Observatory, Broad Institute of MIT and Harvard

This publication has 55 references indexed in Scilit: